<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Lopinavir are protease inhibitors that are usually used to treat human immunodeficiency virus infection with and a booster drug ritonavir. Lopinavir and/or ritonavir have 
 <italic>in vitro</italic> anti-coronaviral activity; they inhibit the proteases, which are important enzymes for polyprotein processing in coronaviruses. 
 <italic>In vitro</italic> studies have reported that lopinavir can inhibit SARS-CoV, and the EC
 <sub>50</sub> of lopinavir is acceptable. Against SARS-CoV-2, lopinavir showed efficacy in Vero E6 cells, with an estimated EC
 <sub>50</sub> of 26.62 μM [
 <xref rid="bib56" ref-type="bibr">56</xref>].
</p>
